Pharmaceuticals (9)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE lists 6,44,360 new equity shares of Fredun Pharmaceuticals Limited issued on a preferential basis at Rs. 1250/- per share, effective … | |||||||||||||||
BSE lists 6,44,360 new equity shares of Fredun Pharmaceuticals Limited issued on a preferential basis at Rs. 1250/- per share, effective March 4, 2026, with a lock-in period until September 15, 2026.
| |||||||||||||||
SEBI modifies the General Remittance Order issued under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals … | |||||||||||||||
SEBI modifies the General Remittance Order issued under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals Limited, adjusting recovery enforcement terms.
| |||||||||||||||
SEBI issues a modification to the Notice of Attachment under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals … | |||||||||||||||
SEBI issues a modification to the Notice of Attachment under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals Limited, amending previously attached assets or attachment details in ongoing recovery proceedings.
| |||||||||||||||
BSE lists 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code 524314) issued to promoters on a preferential basis, … | |||||||||||||||
BSE lists 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code 524314) issued to promoters on a preferential basis, effective February 25, 2026. Shares are locked in until June 16, 2027.
| |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of J.B. Chemicals & Pharmaceuticals Limited at INR 1,639.18 per … | |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of J.B. Chemicals & Pharmaceuticals Limited at INR 1,639.18 per equity share under SEBI (SAST) Regulations.
| |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of J.B. Chemicals & Pharmaceuticals Limited's expanded share … | |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of J.B. Chemicals & Pharmaceuticals Limited's expanded share capital at INR 1,639.18 per equity share under SEBI (SAST) Regulations.
| |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of expanded share capital of J.B. Chemicals & Pharmaceuticals … | |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 26% of expanded share capital of J.B. Chemicals & Pharmaceuticals Limited at INR 1,639.18 per equity share.
| |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 4.17 crore equity shares (26% of expanded share capital) of J.B. … | |||||||||||||||
Torrent Pharmaceuticals Limited announces open offer to acquire up to 4.17 crore equity shares (26% of expanded share capital) of J.B. Chemicals & Pharmaceuticals Limited at INR 1,639.18 per share.
| |||||||||||||||
BSE circular detailing the listing of new equity shares of Novelix Pharmaceuticals Limited with lock-in periods ending in March 2026-2027. | |||||||||||||||
BSE circular detailing the listing of new equity shares of Novelix Pharmaceuticals Limited with lock-in periods ending in March 2026-2027.
| |||||||||||||||